Biodesix, Inc. (BDSX)
Nasdaq: BDSX · Services-Medical Laboratories · Louisville, CO · filing with the SEC since 2008
Who runs Biodesix, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Hutton Scott
President & CEO. First filing Oct 2020, latest Feb 23, 2026, 20 filings in all.
Officers reporting now
6
of 12 people with a filing in the last fifteen months
Directors reporting now
6
15 people on the record since 2020
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Patience John | Chairman | Oct 2020 | Oct 2, 2026 | none |
| Hutton Scott | President & CEO | Oct 2020 | Feb 23, 2026 | 3 · $100,000 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer | Oct 2020 | Feb 23, 2026 | 3 · $0.00 |
| O'Kane Kieran | Chief Commercial Officer | Oct 2020 | Feb 23, 2026 | 3 · $0.00 |
| Pestano Gary Anthony | Chief Development Officer | Oct 2020 | Feb 23, 2026 | 3 · $0.00 |
| Vazquez Chris | Chief Accounting Officer | Jul 2023 | Feb 23, 2026 | 3 · $0.00 |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Schuler Jack W | director | Oct 2020 | Nov 12, 2026 | none |
| Franchi Jean M. | director | Oct 2020 | Jan 6, 2026 | none |
| Kayyem Jon Faiz | director | Dec 2021 | Jan 6, 2026 | none |
| Kennedy Lawrence T. Jr | director | Apr 2022 | Jan 6, 2026 | none |
| Massarany Hany | director | Oct 2020 | Jan 6, 2026 | none |
| Strobeck Matthew | director | Oct 2020 | Jan 6, 2026 | none |
Earlier names on the record3, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.